tiprankstipranks
Trending News
More News >
cbdMD (YCBD)
:YCBD
US Market

cbdMD (YCBD) Earnings Dates, Call Summary & Reports

Compare
418 Followers

Earnings Data

Report Date
Feb 12, 2026
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
-0.06
Last Year’s EPS
-1.76
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Dec 19, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted significant improvements in operating losses, EBITDA, and balance sheet strength. The company made progress with its Oasis beverage brand and restored compliance with exchange requirements. However, there were challenges with declining e-commerce sales, increased SG&A expenses, and overall sales decline. The executive order on cannabis policy presents potential opportunities, although its impact remains uncertain.
Company Guidance
During cbdMD's fiscal year 2025 earnings call, the company highlighted several key metrics and strategic initiatives. The company achieved significant progress in reducing its operating loss by $1.2 million to approximately $2.1 million, marking the third consecutive year of improved operating results. Additionally, adjusted non-GAAP EBITDA improved to a $900,000 loss from a $1.7 million loss in 2024, driven by disciplined cost control and supply chain optimization. cbdMD also focused on balance sheet strengthening, increasing net book value from under $2 million to over $7 million by eliminating over $7 million in annual accrued preferred dividend obligations. The company reported total net sales of $19.1 million for fiscal 2025, a slight decline from $19.5 million in the previous year, with e-commerce representing 77% of total net sales. The company expanded its beverage brand, Oasis, to nine states and closed $2.25 million in additional financing, establishing a $20 million equity line of credit. cbdMD also emphasized its strategic positioning amid evolving federal cannabis policy, following a White House executive order supporting cannabis rescheduling and potential Medicare reimbursement pathways for CBD products.
Improved Operating Loss
Operating loss reduced by $1.2 million to approximately $2.1 million, representing the third consecutive year of improved operating results.
Adjusted EBITDA Improvement
Adjusted non-GAAP EBITDA improved from a $1.7 million loss in 2024 to a $900,000 loss in 2025.
Oasis Beverage Brand Expansion
Distribution of Oasis expanded across 9 states with improving case sell-through and growing distributor engagement.
Balance Sheet Strengthening
Net book value increased from under $2 million to over $7 million, with significant reduction in capital structure complexity.
Restored Exchange Compliance
Compliance deficiencies fully resolved with the NYSE American, reflecting progress in financial stability.
Executive Order on Federal Cannabis Policy
A significant executive order was issued to modernize federal cannabis policy, potentially influencing Medicare reimbursement pathways for CBD products.
Wholesale Business Growth
Wholesale business generated $1.2 million in Q4 2025, up 25% compared to the previous year.
Gross Margin Increase
Gross profit as a percentage of net sales increased to 59% in Q4 2025 compared to 54% in the prior year.

cbdMD (YCBD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

YCBD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 12, 2026
2026 (Q1)
-0.06 / -
-1.76
Dec 19, 2025
2025 (Q4)
-0.07 / 2.78
0
Aug 14, 2025
2025 (Q3)
-0.02 / -0.21
-1.282.50% (+0.99)
May 15, 2025
2025 (Q2)
-1.60 / -1.90
-10.882.41% (+8.90)
Feb 13, 2025
2025 (Q1)
- / -1.76
-5.3667.16% (+3.60)
Dec 18, 2024
2024 (Q4)
-3.60 / 0.00
-46.96
Aug 14, 2024
2024 (Q3)
-4.96 / -1.20
-9.2887.07% (+8.08)
May 15, 2024
2024 (Q2)
-6.00 / -10.80
-13.9222.41% (+3.12)
Feb 13, 2024
2024 (Q1)
-5.92 / -5.36
-28.881.39% (+23.44)
Dec 22, 2023
2023 (Q4)
-6.08 / -46.96
-11.595-305.00% (-35.37)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

YCBD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Dec 19, 2025
$1.51$1.37-9.27%
Aug 14, 2025
$0.85$0.76-10.59%
May 15, 2025
$0.99$0.95-4.04%
Feb 13, 2025
$4.56$3.87-15.13%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does cbdMD (YCBD) report earnings?
cbdMD (YCBD) is schdueled to report earning on Feb 12, 2026, Before Open (Confirmed).
    What is cbdMD (YCBD) earnings time?
    cbdMD (YCBD) earnings time is at Feb 12, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is YCBD EPS forecast?
          YCBD EPS forecast for the fiscal quarter 2026 (Q1) is -0.06.